News

Biomarkers of Interstitial Lung Disease in Sjögren’s Syndrome Identified in Study

Age, disease duration, and blood levels of inflammatory markers Krebs von den Lungen-6 (KL-6) and TNF-alpha are the most discriminating factors for identifying Sjögren’s syndrome patients with interstitial lung disease, a study found. While less significantly associated, other inflammatory markers, including immunoglobulin M (IgM), c-reactive protein (CRP), eotaxin, and…

Sjögren’s Patients More Likely to Need Hospital Care Due to Infections

People with Sjögren’s syndrome are more likely to require inpatient hospital care for infections acquired in the community, especially those of the airways and intestines, according to a large nationwide French study. “[Sjögren’s] patients had a significantly higher incidence rate of hospitalization for bronchopulmonary infections compared with matched [healthy…

Dazodalibep Eases Moderate-to-high Disease Activity in Sjögren’s Patients: Trial Data

The investigational therapy dazodalibep markedly eased disease activity in people with Sjögren’s syndrome with moderate-to-high systemic disease activity, meeting the primary goal of a Phase 2 trial. Ahead of expectations, the therapy’s developer, Horizon Therapeutics, plans to work with the U.S. Food and Drug Administration (FDA) to design…

Memory Problems Common in Sjögren’s, Linked to Global Cognitive Impairment

Memory complaints in people with primary Sjögren’s syndrome are linked to global cognitive impairment — problems affecting not only memory but also other mental faculties, according to data from a small study. While researchers noted that “associated psychiatric and sleep disorders greatly interfere” with cognition in Sjögren’s patients, they…